Articles by Eliot A. Brinton (7)

Discontinuation Rate Due to Flushing Is Less than 6% Following Therapy with a Proprietary Niacin Extended-Release

Eliot A. Brinton, Ping Jiang, Moti Kashyap, Robert Padley, Jeffrey Salon, Roopal Thakkar and Anthony Vo

Journal of Clinical Lipidology 2 ( 3 ): 210 - 211 , 2008

The importance of non-HDL cholesterol reporting in lipid management

Michael J. Blaha, Roger S. Blumenthal, Eliot A. Brinton and Terry A. Jacobson

Journal of Clinical Lipidology 2 ( 4 ): 267 - 273 , 2008

Extended-Release Niacin/Laropiprant Significantly Improves Lipid Levels in Type 2 Diabetes Patients Irrespective of Baseline Glycemic Control

Harold E. Bays, Eliot A. Brinton, Joseph Triscari, Erluo Chen, Darbie Maccubbin, Alexandra MacLean, Kendra Gibson, Amy O. Johnson-Levonas and Yale B. Mitchel

Journal of Clinical Lipidology 6 ( 3 ): 270 - 271 , 2012

Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

Jerome D. Cohen, Eliot A. Brinton, Matthew K. Ito and Terry A. Jacobson

Journal of Clinical Lipidology 6 ( 3 ): 208 - 215 , 2012

Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake: Still problematic after the primary publication

Eliot A. Brinton

Journal of Clinical Lipidology 6 ( 4 ): 312 - 317 , 2012

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education

Melissa Y. Wei, Matthew K. Ito, Jerome D. Cohen, Eliot A. Brinton and Terry A. Jacobson

Journal of Clinical Lipidology 7 ( 5 ): 472 - 483 , 2013

Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: A subanalysis of the USAGE study

Matthew K. Ito, Kevin C. Maki, Eliot A. Brinton, Jerome D. Cohen and Terry A. Jacobson

Journal of Clinical Lipidology 8 ( 1 ): 69 - 76 , 2014